U.S. investment fund Bain Capital may not launch a tender offer for Japanese system developer Fuji Soft Inc., it has been ...

Bain Capital is considering withdrawing its tender offer for Japanese IT firm Fuji Soft after rival U.S. private equity giant ...

U.S. private equity firm Bain Capital said it may withdraw its tender offer proposal for Japanese IT firm Fuji Soft, after ...

TOKYO -- U.S. private equity firm Bain Capital said Monday that backing down on a proposed tender offer for Japanese systems ...

Tanabe Pharma focuses on therapeutic areas such as immunology and inflammation, vaccines, diabetes, and central nervous ...

TOKYO -- The jockeying to acquire Fuji Soft has exposed a hole in Japanese tender offer regulations that has allowed Bain Capital to vie with fellow U.S.-based private equity firm KKR without going ...

Private equity firm Bain Capital agreed to acquire Mitsubishi Chemical Group’s pharmaceutical unit, adding to a dealmaking ...

The US-based private equity firm and Mitsubishi are finalising details of a transaction that could be announced as soon as ...

Bain Capital is nearing a deal to buy Mitsubishi Chemical Group Corp.’s pharmaceutical unit, people familiar with the matter ...

Citi analyst Christopher Allen reiterated a Buy rating on KKR & Co (KKR – Research Report) today. The company’s shares closed yesterday at ...

KKR increased the offer after Bain Capital said in December it could offer a tender price of 9,600 yen a share, higher than KKR's original offer. Fuji Soft's share price has more than doubled over the ...